Table 1 Demographics and clinical characteristics of the study population
Participants (n=696) | Age 20–40 years (n, %) | Age 41–60 years (n, %) | Age 61–80 years (n, %) | Male (n, %) |
|---|---|---|---|---|
Healthy subjects (n=100) | 32 (32%) | 35 (35%) | 33 (33%) | 50 (50%) |
HTN pts. (n=299) | 96 (32.1%) | 105 (35.1%) | 98 (32.7%) | 148 (49.4%) |
HTN mild (n=100) | 33 (33%) | 34 (34%) | 33 (33%) | 48 (48%) |
HTN moderate (n=100) | 31 (31%) | 35 (35%) | 34 (34%) | 53 (53%) |
HTN severe (n=99) | 32 (31.68%) | 36 (35.64%) | 31 (30.69%) | 47 (46.53%) |
DD pts. (n=297) | 95 (31.9%) | 99 (33.3%) | 103 (34.6%) | 153 (51.5%) |
DD impaired relax. (n=101) | 32 (31.7%) | 34 (33.7%) | 35 (34.6%) | 47 (46.5%) |
DD pseudonormal. (n=99) | 32 (32.3%) | 33 (33.3%) | 34 (34.3%) | 52 (52.5%) |
DD restriction (n=97) | 31 (32%) | 32 (33%) | 34 (35%) | 54 (55.7%) |
Subjects in the groups (n, %) | 223 (32%) | 239 (34.3%) | 234 (33.6%) | 352 (50.6%) |